A proteomics-driven 24-protein classifier improves the differentiation of thyroid adenoma and carcinoma, retrospectively and ...

The liposarcoma pipeline report provides detailed profiles of pipeline assets, a comparative analysis of clinical and non-clinical stage liposarcoma drugs, inactive and dormant assets, a comprehensive ...

Novel combination with efti has met the trial's primary endpoint of tumour hyalinization/fibrosis in the neoadjuvant setting ...

Klein’s cancer journey has coincided with her career reaching new heights. She’s ushered SEG through one of its busiest ...

HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:​HCM; HKEX:​13) today announces that new data from several studies of compounds discovered by HUTCHMED including savolitinib, ranosidenib, ...

Forthcoming press releases will feature additional notable oral abstracts. More information on all MD Anderson ASCO Annual ...

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced that data from more ...

Plasma-activated medium (PAM) shows tumor-fighting effects against the rare form of cancer known as synovial sarcoma, an Osaka Metropolitan University-led research team has found. The group ...

Credit: Getty Images A liposarcoma is a type of soft tissue sarcoma, which is a rare type of cancer, that begins in fat cells. A lipoma is a noncancerous tumor that develops just beneath the skin.

Jonsson Comprehensive Cancer Center, The University of California Los Angeles, Los Angeles, CA, USA aaDivision of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA ...